Isracann Biosciences Inc (ISCNF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Mar 28, 16:00
Isracann Biosciences Cash from Operations (TTM): -1.162M for Aug. 31, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
August 31, 2022 | -1.162M |
May 31, 2022 | -1.391M |
February 28, 2022 | -2.027M |
November 30, 2021 | -2.431M |
August 31, 2021 | -2.963M |
May 31, 2021 | -3.270M |
February 28, 2021 | -3.423M |
November 30, 2020 | -5.023M |
August 31, 2020 | -7.302M |
May 31, 2020 | -7.768M |
February 29, 2020 | -5.845M |
November 30, 2019 | -3.970M |
August 31, 2019 | -2.195M |
May 31, 2019 | -2.225M |
February 28, 2019 | -3.804M |
November 30, 2018 | -4.728M |
August 31, 2018 | -3.412M |
May 31, 2018 | -2.306M |
February 28, 2018 | -1.729M |
November 30, 2017 | -0.3397M |
August 31, 2017 | -0.202M |
May 31, 2017 | -0.368M |
February 28, 2017 | -0.2983M |
Date | Value |
---|---|
November 30, 2016 | -0.2594M |
August 31, 2016 | -0.2565M |
May 31, 2016 | -0.0182M |
February 29, 2016 | -0.0425M |
November 30, 2015 | -0.0288M |
August 31, 2015 | -0.0457M |
May 31, 2015 | -0.2393M |
February 28, 2015 | -0.2598M |
November 30, 2014 | -0.2616M |
August 31, 2014 | -0.2366M |
May 31, 2014 | -0.0833M |
February 28, 2014 | -0.0661M |
November 30, 2013 | -0.0717M |
August 31, 2013 | -0.0814M |
May 31, 2013 | -0.087M |
February 28, 2013 | -0.0996M |
November 30, 2012 | -0.1032M |
August 31, 2012 | -0.1088M |
May 31, 2012 | -0.0644M |
February 29, 2012 | -0.0525M |
November 30, 2011 | -0.0552M |
August 31, 2011 | -0.1012M |
May 31, 2011 | -0.1439M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-7.768M
Minimum
May 2020
-1.162M
Maximum
Aug 2022
-3.643M
Average
-3.116M
Median
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Edesa Biotech Inc | -6.252M |
Lexaria Bioscience Corp | -5.818M |
Liminal Biosciences Inc (DELISTED) | -27.11M |